We here examined the relationship between alterations in NRAS, BRAF, and p16CDKN2A genes in both in vivo melanoma tissues (N = 35) from southern Italian patients and in vitro melanoma cell lines (N = 18). This evidence concerns the gene NRAS and melanoma.